Triple

T16851818
Position Surface form Disambiguated ID Type / Status
Subject GILD E409692 entity
Predicate issuerFounder P104 FINISHED
Object Michael L. Riordan E419528 NE FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Michael L. Riordan | Statement: [GILD, issuerFounder, Michael L. Riordan]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Michael L. Riordan
Context triple: [GILD, issuerFounder, Michael L. Riordan]
  • A. Michael L. Riordan chosen
    Michael L. Riordan is an American physician and entrepreneur best known as the founding CEO of the biopharmaceutical company Gilead Sciences.
  • B. Richard J. Riordan
    Richard J. Riordan was an American businessman, philanthropist, and Republican politician who served as mayor of Los Angeles from 1993 to 2001.
  • C. Randal A. Ball
    Randal A. Ball is an individual notable enough to be specifically cited as a bearer of the surname Ball, though detailed public information about his life or achievements is limited.
  • D. Michael V. Drake
    Michael V. Drake is an American academic leader and physician who has served as president of both The Ohio State University and the University of California system.
  • E. Stephen F. Martin
    Stephen F. Martin is an American organic chemist renowned for his influential research in synthetic methodology and complex molecule synthesis.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d88395e6c88190b22730f335107c14 completed April 10, 2026, 4:59 a.m.
NER Named-entity recognition batch_69e3b379b8fc81908d8bc9950c7f8bad completed April 18, 2026, 4:38 p.m.
NED1 Entity disambiguation (via context triple) batch_6a00d452505c8190b6d37b54b2f665f0 completed May 10, 2026, 6:54 p.m.
Created at: April 10, 2026, 5:24 a.m.